Summary.-Using the data described in Paper I, we compare the effects of the same treatment timings and doses given at different ages. Initiation with DMBA at 68 weeks of age, followed 3 weeks later by TPA, has a significantly (P < 0.0001) less rapid effect on subsequent tumour incidence than does initiation at 8 or at 48 weeks of age, followed 3 weeks later by TPA. We suggest that this is chiefly due not to changes in the numbers of cells initiated by DMBA, but rather to a decrease in the promotional efficacy of TPA in ageing mice.
MAN-r qualitatively different processes
have been found to affect cancer induction, and the most promising framework for an eventual synthesis of these several different mechanisms into a coherent description of the natural history of cancer is, especially for epithelial tumours, some kind of multi-stage model. One simplifying assumption commonly made when formulating multi-stage models (e.g. Armitage & Doll, 1961;  Peto, 1977; Whittemore & Keller, 1.978) is that age per se has little or no intrinsic relevance to the processes of cancer induiction. § This assumption predicts that, for a particular carcinogenic treatment which strongly affects, inter alia, the first stage of cancer induction, the cancer risk within a fixed time after that treatment began should not, in general, depend strongly on how old the animal was when the treatment began (excluding the peculiarly vulnerable foetal and neonatal periods). This is an easy prediction to test experimentally but, despite this, there is surprisingly little published evidence available about the effects of age on the carcinogenicity of treatments which include some initiation. The most direct experimental evidence (and a review of other experimental and epidemiological evidence) is perhaps that given by Peto et al. (1975) , who found that when mice were given 20 Hg of benzpyrene twice weekly, starting at ages 10, 25, 40 or 55 weeks of age and continuing indefinitely thereafter, the resultant cancer risk was independent of age. The risk depended strongly on how long the treatment had been given, of course, but among animals of different ages which had all been treated for the same length of time the cancer incidence rate did not depend on age. of the sequence of processes which are presumably involved in cancer induction seemed to be unaffected by the age of the animals. However, if the first stage was easier to induce in older animals and some later stage was more difficult to induce, these two effects could, in principle, approximately cancel out, leaving the final cancer incidence rate largely independent of age (among animals treated for the same duration), as observed. The present study examines the dependence on age at initiation in a system which, unlike that studied by Peto et al. (1975) does involve specific promotional stimuli (due either to wound healing or to use of a promoting agent) and some quite marked dependences now emerge. If the ease with which promotion can operate does vary markedly with age, all attempts to make a "multi-stage" synthesis of what is known about initiation and promotion will be seriously incomplete unless this age dependence is allowed for.
METHODS
Among the 9 treatment groups of the initiation/promotion experiment described in the accompanying paper (Stenback et al., 1981) there are some groups which have the same interval between initiation and the start of promotion, and which differ only in the age of the animals during treatment. These groups, and the analyses which we shall perform on them, are listed in the Table. We can assess separately the dependence on age at treatment of the effects of (a) initiation followed by immediate promotion, (b) initiation followed by delayed promotion, and (c) initiation without promotion.
In each case, we may assess the response either in terms of (i) the total number of tumours arising within a particular 20-week period of time (to which one mouse may contribute more than one tumour, which makes the calculation of reliable P values difficult), or in terms of (ii-iv) Tables e and f) . This is odd, since it concerns an agent rather similar to that studied by Peto et al. (1975) with which no age-related changes in effect were evident (and see also the footnote to Appendix Whittemore & Keller, 1978) , almost all of which imWhatever the plicity or explicitly assumes that some or in the effects all of the transitions through which cells Ltes that, in pass en route from normality to full transr marked de-formation are largely independent of age. iitiation with Our data show clearly that such assump- Fig. 1 Incidence rates of (ii) first tumours irrespective of size or type, (iii) first 10 mm tumours, and (iv) first malignant tumours, among animals initiated at various ages and promoted from Weeks 3-18 thereafter. The expected numbers. E, and P values were calculated using methods of analysis appropriate for in vivo tumours, using the times wben (ii) appearance, (iii) size > 10 mm and (iv) apparent malignancy were first noted.
N=Number of animals alive at the end of Week 3 after initiation, excluding any which had already developed the tumour type of interest. 0 = Number of such animals which were Observed to develop the tumour type of interest at any time after Week-3.
E =Number of such animals Expected to do so if onset rates depend on dose level and on time since initiation but not oI1 age at initiation. These Expecteds were calculated using the methods described for tumours observed in a mortality-independent context in IARC (1980). 
